Pitcairn’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-12,683
| Closed | -$1.06M | – | 357 |
|
|
2025
Q3 | $1.06M | Sell |
12,683
-3,132
| -20% | -$258K | 0.08% | 211 |
|
|
2025
Q2 | $1.25M | Sell |
15,815
-2,889
| -15% | -$230K | 0.08% | 220 |
|
|
2025
Q1 | $1.68M | Sell |
18,704
-3,265
| -15% | -$305K | 0.1% | 177 |
|
|
2024
Q4 | $2.19M | Buy |
21,969
+353
| +2% | +$36.4K | 0.13% | 141 |
|
|
2024
Q3 | $2.45M | Sell |
21,616
-3,927
| -15% | -$467K | 0.15% | 128 |
|
|
2024
Q2 | $3.16M | Buy |
25,543
+1,958
| +8% | +$252K | 0.19% | 101 |
|
|
2024
Q1 | $3.11M | Buy |
23,585
+779
| +3% | +$96K | 0.2% | 99 |
|
|
2023
Q4 | $2.49M | Sell |
22,806
-202
| -0.9% | -$21K | 0.18% | 105 |
|
|
2023
Q3 | $2.37M | Buy |
23,008
+1,178
| +5% | +$127K | 0.2% | 97 |
|
|
2023
Q2 | $2.52M | Buy |
21,830
+190
| +0.9% | +$21.6K | 0.21% | 93 |
|
|
2023
Q1 | $2.3M | Buy |
21,640
+806
| +4% | +$87K | 0.21% | 91 |
|
|
2022
Q4 | $2.31M | Buy |
20,834
+910
| +5% | +$93K | 0.23% | 88 |
|
|
2022
Q3 | $1.72M | Sell |
19,924
-562
| -3% | -$50.2K | 0.19% | 112 |
|
|
2022
Q2 | $1.87M | Buy |
20,486
+1,286
| +7% | +$114K | 0.2% | 100 |
|
|
2022
Q1 | $1.57M | Sell |
19,200
-3,290
| -15% | -$259K | 0.14% | 138 |
|
|
2021
Q4 | $1.72M | Sell |
22,490
-7,328
| -25% | -$584K | 0.11% | 130 |
|
|
2021
Q3 | $2.24M | Sell |
29,818
-4,423
| -13% | -$336K | 0.15% | 91 |
|
|
2021
Q2 | $2.66M | Sell |
34,241
-1,194
| -3% | -$88.8K | 0.18% | 80 |
|
|
2021
Q1 | $2.61M | Buy |
35,435
+4,225
| +14% | +$312K | 0.19% | 80 |
|
|
2020
Q4 | $2.44M | Sell |
31,210
-1,021
| -3% | -$78.1K | 0.19% | 83 |
|
|
2020
Q3 | $2.55M | Sell |
32,231
-3,745
| -10% | -$293K | 0.22% | 68 |
|
|
2020
Q2 | $2.65M | Sell |
35,976
-87
| -0.2% | -$6.55K | 0.26% | 65 |
|
|
2020
Q1 | $2.65M | Sell |
36,063
-947
| -3% | -$74.4K | 0.31% | 45 |
|
|
2019
Q4 | $3.21M | Sell |
37,010
-5,127
| -12% | -$421K | 0.3% | 49 |
|
|
2019
Q3 | $3.38M | Sell |
42,137
-1,614
| -4% | -$129K | 0.33% | 41 |
|
|
2019
Q2 | $3.5M | Buy |
43,751
+571
| +1% | +$43.7K | 0.35% | 40 |
|
|
2019
Q1 | $3.43M | Sell |
43,180
-1,308
| -3% | -$97.8K | 0.37% | 37 |
|
|
2018
Q4 | $3.24M | Buy |
44,488
+21,981
| +98% | +$1.55M | 0.36% | 39 |
|
|
2018
Q3 | $1.52M | Buy |
22,507
+1,309
| +6% | +$83.4K | 0.16% | 82 |
|
|
2018
Q2 | $1.23M | Sell |
21,198
-407
| -2% | -$23K | 0.13% | 99 |
|
|
2018
Q1 | $1.12M | Sell |
21,605
-2,142
| -9% | -$116K | 0.12% | 110 |
|
|
2017
Q4 | $1.27M | Sell |
23,747
-459
| -2% | -$25.4K | 0.13% | 104 |
|
|
2017
Q3 | $1.48M | Sell |
24,206
-1,040
| -4% | -$63.1K | 0.17% | 84 |
|
|
2017
Q2 | $1.54M | Sell |
25,246
-404
| -2% | -$24.6K | 0.19% | 71 |
|
|
2017
Q1 | $1.55M | Buy |
25,650
+687
| +3% | +$41.7K | 0.19% | 75 |
|
|
2016
Q4 | $1.4M | Sell |
24,963
-4,595
| -16% | -$269K | 0.17% | 88 |
|
|
2016
Q3 | $1.76M | Sell |
29,558
-872
| -3% | -$51K | 0.22% | 66 |
|
|
2016
Q2 | $1.67M | Buy |
30,430
+545
| +2% | +$29K | 0.21% | 70 |
|
|
2016
Q1 | $1.51M | Buy |
29,885
+161
| +0.5% | +$7.88K | 0.19% | 85 |
|
|
2015
Q4 | $1.5M | Sell |
29,724
-22,370
| -43% | -$1.13M | 0.17% | 86 |
|
|
2015
Q3 | $2.46M | Sell |
52,094
-4,463
| -8% | -$237K | 0.33% | 44 |
|
|
2015
Q2 | $3.07M | Buy |
56,557
+31,269
| +124% | +$1.75M | 0.35% | 44 |
|
|
2015
Q1 | $1.39M | Sell |
25,288
-1,530
| -6% | -$86.6K | 0.15% | 114 |
|
|
2014
Q4 | $1.45M | Buy |
26,818
+48
| +0.2% | +$2.67K | 0.16% | 111 |
|
|
2014
Q3 | $1.51M | Buy |
26,770
+764
| +3% | +$42.9K | 0.17% | 107 |
|
|
2014
Q2 | $1.44M | Sell |
26,006
-2,992
| -10% | -$163K | 0.16% | 115 |
|
|
2014
Q1 | $1.57M | Sell |
28,998
-2,781
| -9% | -$144K | 0.18% | 101 |
|
|
2013
Q4 | $1.52M | Buy |
31,779
+3,934
| +14% | +$180K | 0.17% | 107 |
|
|
2013
Q3 | $1.26M | Sell |
27,845
-112
| -0.4% | -$5.11K | 0.16% | 117 |
|
|
2013
Q2 | $1.24M | Buy |
+27,957
| New | +$1.25M | 0.17% | 125 |
|
Other funds holding MRK
Pitcairn's MRK Position: Q4 2025 in Review
Pitcairn sold out of Merck (MRK) in Q4 2025, closing a stake of 12,683 shares — an estimated $1.06M sold.
Pitcairn first reported a position in MRK in Q2 2013 and held it in 50 quarters. The position peaked at $3.5M in Q2 2019. 3,651 funds tracked by Wall St. Rank hold MRK as of Q4 2025.
- Pitcairn reported no remaining Merck position as of Q4 2025 after selling out during the quarter.
- Pitcairn sold 12,683 Merck shares in Q4 2025, an estimated $1.06M.
- Pitcairn first reported a position in Merck in Q2 2013 and held it in 50 quarters.
- Pitcairn's Merck position peaked at $3.5M in Q2 2019.
- 3,651 funds tracked by Wall St. Rank held Merck as of Q4 2025.
Based on Pitcairn's 13F filing for Q4 2025.